Abstract

Background

Lichen sclerosus (LSc) is a chronic, inflammatory, destructive skin disease with a predilection for the genitalia (GLSc). An association with vulval (Vu) and penile (Pe) squamous carcinoma (SCC) is now well established but melanoma (MM) has only rarely been reported complicating GLSc.

Methods

We have performed a systematic literature review of GLSc in patients with genital melanoma (GMM). Only articles that mentioned both GMM and LSc affecting either the penis or vulva were included.

Results

Twelve studies with a total of 20 patients were included. Our review shows that an association of GLSc with GMM has been more frequently reported in women and female children than men viz, 17 cases compared with three. It is notable that five of the cases (27.8%) concerned female children aged under twelve.

Discussion

These data suggest a rare association between GLSc and GMM. If proven, there arise intriguing questions about pathogenesis and consequences for counselling of patients and follow-up.

What's already known about this topic?
  • Lichen sclerosus (LSc) is a chronic, inflammatory, destructive, and scarring skin disease with a predilection for the genitalia. Even though genital (G) LSc is thought to be a risk factor for the development of genital squamous cell carcinoma (GSCC), very little is known on the association between GLSc and genital melanoma (GMM).

What does this study add?
  • The association of GLSc with GMM has been more frequently reported in women and children than men. There is no evidence in the published literature that links genital human papillomavirus (HPV) and GMM.

1 Introduction

Lichen sclerosus (LSc) is a chronic, inflammatory, destructive skin disease with a predilection for the genitalia (GLSc). An association with vulval (Vu) and penile (Pe) squamous cell carcinoma (SCC) is now well established.1–3 Reports of an association with genital (G) melanoma (MM) have appeared in the literature. We have previously published three cases of penile (Pe) MM complicating male (M) GLSc and recently encountered another case in our multidisciplinary practice.4 We have therefore undertaken a literature review in an attempt to shed more light on this topic.

2 Methods

We performed a literature search on 8 November 2021 on PubMed (Medline), Cochrane Library, and Embase using prespecified search criteria.

The search terms used were (‘penis’ OR ‘penile’ OR ‘genitalia’ OR ‘genital’ OR ‘vulva’ OR ‘vulvar’ OR ‘vulval’) AND ‘melanoma’ AND (‘lichen sclerosus’ OR ‘lichen’).

Titles and abstracts were screened by two reviewers for relevance. Any discrepancies in findings were resolved by a third, senior reviewer.

We included published articles with GMM amongst patients with known GLSc, in any language, country and publication date. Articles that mentioned GMM alone, without reference to GLSc, were excluded. Likewise, articles that mentioned GLSc alone, without reference to GMM were excluded. Only articles that mentioned both GMM and GLSc on either the penis or vulva were included.

3 Results

A total of 53 articles were identified through our search across all three databases (Embase = 10, Cochrane = 1, PubMed = 42). After excluding four duplicates, the remaining 49 articles were screened through their abstracts and 34 articles were excluded. The remaining 15 articles were then assessed for relevance based on their full text and a total of 12 studies were deemed eligible for inclusion (Figure 1).

PRISMA flow diagram of the article selection process.
FIGURE 1

PRISMA flow diagram of the article selection process.

Twenty patients were reported to have had GLSc associated with MM. There were five cases of female children, 12 cases of adult women, and three cases of adult men.4–15 We strongly suspect however, that the publications by Carlson et al. and Rohwedder et al., both describe the same patient.

Amongst the five cases of female children, there was a 10-year-old with two separate sites of GLSc associated with MM, both found on the left vulva.7

The average ages of the female children, adult women, and adult men were 10, 74, and 40 years, respectively.

The mean Breslow thicknesses of the MMs for female children, adult women, and adult men were 0.55, 6.18, and 0.58 mm, respectively. In three patients this information was not available.

Data on Clark Levels were available in 11 cases with a calculated median value of 4.

Data on lymph node biopsies were available in six patients (five adult women and one female child); only in two (a 10-year-old female with two separate melanomas of the left vulva, and a 59-year-old female) were the lymph node biopsies found to be positive.7,8

Only eight patients had information on the subtype of their melanomas. Of these, three were nodular, three were lentiginous, and two were superficial spreading.

A summary of the patient demographics and clinical findings is presented in Table 1.

TABLE 1

A summary of patient demographics and clinical findings

AuthorYearNo. of patientsAge in yearsGenderSubtype of melanomaClark levelBreslow thickness (in mm)Lymph node biopsy
Ulmer et al.1996160FSuperficial spreading41.4N/A
Egan et al.199729FN/AN/AN/AN/A
11FN/AN/A0.47N/A
Carlson et al.a2002183FNodular42.7Neg.
Rohwedder et al.a2002183FN/A42.7N/A
Hassanein et al.2004110FLentiginous20.44Neg.
Rosamilia et al.2006110FN/AN/A0.36 & 1Pos. & pos.
Rohwedder et al.2007276FLentiginous42N/A
85FNodular47N/A
De Simone et al.20081N/AFSuperficial spreadingN/AN/AN/A
Heinzelmann et al.2014369FN/AN/A1Neg.
81FN/AN/AN/AN/A
84FN/AN/A3.5Neg.
Spina et al.2016111FN/A30.5N/A
Turnbull et al.2016330MLentiginousN/A0.1N/A
40MN/AN/A0.44N/A
50MNodular51.2N/A
Hieta et al.2018359FN/A410Pos.
69FN/A519N/A
79FN/A49N/A
AuthorYearNo. of patientsAge in yearsGenderSubtype of melanomaClark levelBreslow thickness (in mm)Lymph node biopsy
Ulmer et al.1996160FSuperficial spreading41.4N/A
Egan et al.199729FN/AN/AN/AN/A
11FN/AN/A0.47N/A
Carlson et al.a2002183FNodular42.7Neg.
Rohwedder et al.a2002183FN/A42.7N/A
Hassanein et al.2004110FLentiginous20.44Neg.
Rosamilia et al.2006110FN/AN/A0.36 & 1Pos. & pos.
Rohwedder et al.2007276FLentiginous42N/A
85FNodular47N/A
De Simone et al.20081N/AFSuperficial spreadingN/AN/AN/A
Heinzelmann et al.2014369FN/AN/A1Neg.
81FN/AN/AN/AN/A
84FN/AN/A3.5Neg.
Spina et al.2016111FN/A30.5N/A
Turnbull et al.2016330MLentiginousN/A0.1N/A
40MN/AN/A0.44N/A
50MNodular51.2N/A
Hieta et al.2018359FN/A410Pos.
69FN/A519N/A
79FN/A49N/A

a Publications that are suspected to have reported on the same patient.

TABLE 1

A summary of patient demographics and clinical findings

AuthorYearNo. of patientsAge in yearsGenderSubtype of melanomaClark levelBreslow thickness (in mm)Lymph node biopsy
Ulmer et al.1996160FSuperficial spreading41.4N/A
Egan et al.199729FN/AN/AN/AN/A
11FN/AN/A0.47N/A
Carlson et al.a2002183FNodular42.7Neg.
Rohwedder et al.a2002183FN/A42.7N/A
Hassanein et al.2004110FLentiginous20.44Neg.
Rosamilia et al.2006110FN/AN/A0.36 & 1Pos. & pos.
Rohwedder et al.2007276FLentiginous42N/A
85FNodular47N/A
De Simone et al.20081N/AFSuperficial spreadingN/AN/AN/A
Heinzelmann et al.2014369FN/AN/A1Neg.
81FN/AN/AN/AN/A
84FN/AN/A3.5Neg.
Spina et al.2016111FN/A30.5N/A
Turnbull et al.2016330MLentiginousN/A0.1N/A
40MN/AN/A0.44N/A
50MNodular51.2N/A
Hieta et al.2018359FN/A410Pos.
69FN/A519N/A
79FN/A49N/A
AuthorYearNo. of patientsAge in yearsGenderSubtype of melanomaClark levelBreslow thickness (in mm)Lymph node biopsy
Ulmer et al.1996160FSuperficial spreading41.4N/A
Egan et al.199729FN/AN/AN/AN/A
11FN/AN/A0.47N/A
Carlson et al.a2002183FNodular42.7Neg.
Rohwedder et al.a2002183FN/A42.7N/A
Hassanein et al.2004110FLentiginous20.44Neg.
Rosamilia et al.2006110FN/AN/A0.36 & 1Pos. & pos.
Rohwedder et al.2007276FLentiginous42N/A
85FNodular47N/A
De Simone et al.20081N/AFSuperficial spreadingN/AN/AN/A
Heinzelmann et al.2014369FN/AN/A1Neg.
81FN/AN/AN/AN/A
84FN/AN/A3.5Neg.
Spina et al.2016111FN/A30.5N/A
Turnbull et al.2016330MLentiginousN/A0.1N/A
40MN/AN/A0.44N/A
50MNodular51.2N/A
Hieta et al.2018359FN/A410Pos.
69FN/A519N/A
79FN/A49N/A

a Publications that are suspected to have reported on the same patient.

4 Discussion

LSc is a chronic, inflammatory, destructive, and scarring skin disease with a predilection for the genitalia. Female (F) GLSc most commonly affects postmenopausal women with the prevalence estimated to be 1 in 30 older women. FGLSc is also held to be 6-10-fold more common than MGLSc.1 However, the exact incidence and prevalence of GLSC is unknown in males; this is also the case with children. In males the incidence appears trimodal—children, young males, and older males. MGLSc may be much more frequent than is generally supposed in early childhood (being diagnosed histologically in 14%–95% of prepuces removed for phimosis).2,3

FGLSc most commonly affects the genitocrural folds, the inner aspects of labia majora, labia minora, clitoris and clitoral hood. FGLSc is also commonly associated with perianal LSc in a characteristic figure-of-8 distribution.1,2 In MGLSc the disease affects the balanopreputial epithelium and can involve the urethra (which is rare in women). When left undiagnosed and inadequately treated, GLSc can cause dyspareunia, urinary difficulties, scarring, and irreversible architectural and pigmentary changes. It is also associated with a risk of progression to SCC as discussed below.1–3

The pathogenesis of GLSc is controversial, being most likely multifactorial; important postulated hypotheses are chronic irritation of epithelium by urine, dysbiosis, and autoimmunity.16–18

In childhood LSc the risks of vulvar and penile malignancy are unclear. However, in adult women with FGLSc the incidence of VuSCC is thought to be about 4%–12%.1,11 In MGLSc the published rates vary between 0% and 12.5% (with the lower figures from our group, testifying to early, accurate diagnosis and effective definitive treatment).19–22 GLSc has also been reported in association with other neoplasms, including Merkel cell carcinoma, spindle cell carcinoma, vulvar malignant pleomorphic adenoma and basal cell carcinoma, as well as with benign nevi.9,23–26

VuSCC emanating from FGLSc has been postulated to be a consequence of the molecularly altered epithelium created by chronic inflammation and abnormal cytokine and growth-factor production.11,27 In men, the carcinogenic pathway has not previously generated much comment or research but is an active area of investigation by our group.

Mucosal MM is rare, representing less than 2% of all MM.28 Vaginal (Va) and VuMM constitute between 1% and 3% of MM diagnosed in women, while PeMM accounts for 1.4% of primary penile cancers, and less than 0.1% of primary MM.29–31

Vu/Va MM typically occurs in post-menopausal women and has an estimated incidence of 0.10/100 000 women/year.8,15,32 It is even rarer in children, with the incidence of childhood MM cited as being between 0.8 and 8 per million.8,9,33,34

PeMM seems to be even rarer with only approximately 200 cases reported in the literature.31 Our review shows that the association of GLSc with MM has been more frequently reported in women and children than men that is, 17 cases compared with three.4–15 Hence, we plan to review all the cases of PeMM and VuMM seen in our multidisciplinary practice in order to further investigate this.

In most cases MM arises in sun-exposed skin.35 Mucosal MM develops from the epithelium of the oropharynx, gastrointestinal and genital tracts.36 While UV radiation is important in the pathogenesis of cutaneous melanoma, the pathogenesis of mucosal MM is unclear.4 Mucosal and cutaneous MM have genetic, histological, and clinical differences and should therefore be contemplated as distinct entities.8–10,12,30 VuMM presents at a more advanced stage and has a much poorer prognosis than cutaneous MM (47% vs. 80% 5-year survival).12,13,15,30,32,37–39 This is thought to be due to the essential biological aggressiveness of the neoplasm, the lack of early symptoms, a thin underlying dermis, delayed diagnosis, and less radical surgical therapy.15,40,41 PeMM is similarly considered to be an aggressive malignancy.31

Even though ultraviolet radiation is an important aetiological factor for cutaneous MM, this cannot be a factor in genital melanomagenesis.15 Therefore, the mutagenic agents involved in Vu and PeMM are likely to involve local stressors such as chronic inflammation, genital melanosis, viral infections (such as HPV), irritant agents, and perhaps genetic susceptibility.9,12,13,15,42 In the paper by Hieta et al., it was found that 12% (30/249) of patients with FGLSc had VuSCCs, but only 0.01% (3/249) had VuMM.11 But, they calculated that the risk of VuMM among patients with FGLSc was 341 times higher than the risk in women with no GLSc.11

The higher incidence of vulvar SCC among patients with LSc has been postulated to be a result of the molecularly altered epithelium generated by the effects of chronic inflammation with abnormal cytokine and growth-factor production.11,27

While melanocytic nevi can be found coinciding with GLSc, in two cases of MM associated with GLSc the histologic changes of LSc were found at the periphery of the MM but not immediately adjacent to or underlying the MM.9,12,43 LSc always vanished beneath the invasive melanoma, where dermal hyalinization was replaced by fibrosis.10

HPV has been detected in GLSc and it has been postulated that the inflammatory environment of LSc may generate a pro-oxidative environment that, in conjunction with oncogenic HPV, produces a field effect that initiates and facilitates development of MM.9,12,44–52 Keratinocytes and melanocytes in the epithelium affected by LSc may be more vulnerable to oxidative and genotoxic insults because the lack of melanin would normally confer some protection.53–56

However, although HPV has also been detected in both primary melanoma and acquired dysplastic melanocytic naevi, the association between HPV and MM is still unclear. High-risk HPV was not identified in association with MM in neither of the studies by Rohwedder et al. and Ueda et al.12,13,57,58

It remains the case that an underlying mechanism to explain the association between GLSc and GMM has yet to be elucidated. However, a possible hypothesis is that chronic melanocytic distress is created by a pro-oxidative environment that increases mutagenesis and attenuates or disrupts local protective mechanisms.9

The limited number of reports on the association of GLSc with GMM may be partly due to lack of recognition of the link between the two conditions, as well as under-reporting.10,43,59 The striking histological features of MM are likely to overshadow the more subtle features of MGLSc. In addition, melanosis in GLSc is common, and melanocytic proliferations in GLSc can be challenging to interpret, with benign melanocytic nevi occurring in GLSc sometimes histologically resembling malignant melanoma.5,6,9,43,60–67

Despite the small number of reports, it is likely that the colocalization between GMM and GLSc is much more common than originally thought. Clinicians need to be aware of this important association in order to counsel and follow-up patients accordingly.

Conflict of Interest

The authors have no conflicts of interest to disclose.

Author Contributions

Sharmaine Sim: Conceptualization (Equal); Formal analysis (Equal); Methodology (Equal); Project administration (Equal); Writing – original draft (Equal); Writing – review & editing (Equal). Katherine Dear: Conceptualization (Equal); Formal analysis (Equal); Methodology (Equal); Project administration (Equal); Writing – original draft (Equal); Writing – review & editing (Equal). Evanthia Mastoraki: Conceptualization (Equal); Formal analysis (Equal); Methodology (Equal); Project administration (Equal); Writing – original draft (Equal); Writing – review & editing (Equal). Mariel James: Conceptualization (Equal); Formal analysis (Equal); Methodology (Equal); Project administration (Equal); Writing – original draft (Equal); Writing – review & editing (Equal). Aiman Haider: Conceptualization (Equal); Formal analysis (Equal); Methodology (Equal); Project administration (Equal); Writing – original draft (Equal); Writing – review & editing (Equal). Peter Ellery: Conceptualization (Equal); Formal analysis (Equal); Methodology (Equal); Project administration (Equal); Writing – original draft (Equal); Writing – review & editing (Equal). Alex Freeman: Conceptualization (Equal); Formal analysis (Equal); Methodology (Equal); Project administration (Equal); Writing – original draft (Equal); Writing – review & editing (Equal). Hussain M. Alnajjar: Conceptualization (Equal); Formal analysis (Equal); Methodology (Equal); Project administration (Equal); Writing – original draft (Equal); Writing – review & editing (Equal). Asif Muneer: Conceptualization (Equal); Formal analysis (Equal); Methodology (Equal); Project administration (Equal); Writing – original draft (Equal); Writing – review & editing (Equal). Richard Watchorn: Conceptualization (Equal); Formal analysis (Equal); Methodology (Equal); Project administration (Equal); Writing – original draft (Equal); Writing – review & editing (Equal). Georgios Kravvas: Conceptualization (Equal); Formal analysis (Equal); Methodology (Equal); Project administration (Equal); Resources (Lead); Supervision (Lead); Writing – original draft (Equal); Writing – review & editing (Equal). Christopher B. Bunker: Conceptualization (Equal); Formal analysis (Equal); Methodology (Equal); Project administration (Equal); Resources (Lead); Supervision (Lead); Writing – original draft (Equal); Writing – review & editing (Equal).

Data Availability Statement

Data sharing is not applicable to this article as no new data were created or analyzed in this study.

Ethics Statement

Not applicable.

Acknowledgement

Partially funded by anonymous donation via the British Skin Foundation.

References

1

Lewis
F
. Dermatoses of the female genitalia. In:
Griffiths
C
,
Barker
J
,
Bleiker
T
,
Chalmers
R
,
Creamer
T
, editors.
Rook's textbook of dermatology
. 9th ed.
Chichester
:
Wiley-Blackwell
;
2016
. p. 4696 p.

2

Bunker
CB
,
Watchorn
R
. Dermatoses of the male genitalia. In:
Griffiths
C
,
Barker
J
,
Bleiker
T
, editors.
Rook's textbook of dermatology
. 10th ed.
Chichester
:
Wiley-Blackwell
(in press).

3

Bunker
CB
.
Male genital skin disease
. 2nd ed.
London
:
Bruce Shrink
;
2019
.

4

Turnbull
N
,
Shim
T
,
Patel
N
,
Mazzon
S
,
Bunker
C
.
Primary melanoma of the penis in 3 patients with lichen sclerosus
.
JAMA Dermatol
.
2016
;
152
(
2
):
226
227
.

5

Egan
CA
,
Bradley
RR
,
Logsdon
VK
,
Summers
BK
,
Hunter
GR
,
Vanderhooft
SL
.
Vulvar melanoma in childhood
.
Arch Dermatol
.
1997
;
133
(
3
):
345
348
.

6

Hassanein
AM
,
Mrstik
ME
,
Hardt
NS
,
Morgan
LA
,
Wilkinson
EJ
.
Malignant melanoma associated with lichen sclerosus in the vulva of a 10-year-old
.
Pediatr Dermatol
.
2004
;
21
(
4
):
473
476
.

7

Rosamilia
LL
,
Schwartz
JL
,
Lowe
L
,
Gruber
SB
,
Quint
EH
,
Johnson
TM
, et al.
Vulvar melanoma in a 10-year-old girl in association with lichen sclerosus
.
J Am Acad Dermatol
.
2006
;
54
(
2 Suppl
):
S52
S53
.

8

La Spina
M
,
Meli
MC
,
De Pasquale
R
,
Perrotta
RE
,
Lanzafame
S
,
Caltabiano
R
, et al.
Vulvar melanoma associated with lichen sclerosus in a child: case report and literature review
.
Pediatr Dermatol
.
2016
;
33
(
3
):
e190
e194
.

9

Carlson
JA
,
Mu
XC
,
Slominski
A
,
Weismann
K
,
Crowson
AN
,
Malfetano
J
, et al.
Melanocytic proliferations associated with lichen sclerosus
.
Arch Dermatol
.
2002
;
138
(
1
):
77
87
.

10

Heinzelmann-Schwarz
VA
,
Nixdorf
S
,
Valadan
M
,
Diczbalis
M
,
Olivier
J
,
Otton
G
, et al.
A clinicopathological review of 33 patients with vulvar melanoma identifies c-KIT as a prognostic marker
.
Int J Mol Med
.
2014
;
33
(
4
):
784
794
.

11

Hieta
N
,
Kurki
S
,
Rintala
M
,
Söderlund
J
,
Hietanen
S
,
Orte
K
.
Association of vulvar melanoma with lichen sclerosus
.
Acta Derm Venereol
.
2019
;
99
(
3
):
339
340
.

12

Rohwedder
A
,
Philips
B
,
Malfetano
J
,
Kredentser
D
,
Carlson
JA
.
Vulvar malignant melanoma associated with human papillomavirus DNA: report of two cases and review of literature
.
Am J Dermatopathol
.
2002
;
24
(
3
):
230
240
.

13

Rohwedder
A
,
Slominski
A
,
Wolff
M
,
Kredentser
D
,
Carlson
JA
.
Epidermodysplasia verruciformis and cutaneous human papillomavirus DNA, but not genital human papillomavirus DNAs, are frequently detected in vulvar and vaginal melanoma
.
Am J Dermatopathol
.
2007
;
29
(
1
):
13
17
.

14

Ulmer
A
,
Dietl
J
,
Schaumburg-Lever
G
,
Fierlbeck
G
.
Amelanotic malignant melanoma of the vulva. Case report and review of the literature
.
Arch Gynecol Obstet
.
1996
;
259
(
1
):
45
50
.

15

De Simone
P
,
Silipo
V
,
Buccini
P
,
Mariani
G
,
Marenda
S
,
Eibenschutz
L
, et al.
Vulvar melanoma: a report of 10 cases and review of the literature
.
Melanoma Res
.
2008
;
18
(
2
):
127
133
.

16

Kravvas
G
,
Muneer
A
,
Watchorn
R
,
Castiglione
F
,
Haider
A
,
Freeman
A
, et al.
Male genital lichen sclerosus, micro incontinence and occlusion: mapping the disease across the prepuce
.
Clin Exp Dermatol
.
2022
;
47
(
6
):
1124
1130
.

17

Watchorn
RE
,
van den Munckhof
EHA
,
Quint
KD
,
Eliahoo
J
,
de Koning
MNC
,
Quint
WGV
, et al.
Balanopreputial sac and urine microbiota in patients with male genital lichen sclerosus
.
Int J Dermatol
.
2021
;
60
(
2
):
201
207
.

18

Fergus
KB
,
Lee
AW
,
Baradaran
N
,
Cohen
AJ
,
Stohr
BA
,
Erickson
BA
, et al.
Pathophysiology, clinical manifestations, and treatment of lichen sclerosus: a systematic review
.
Urology
.
2020
;
135
:
11
19
.

19

Kravvas
G
,
Ge
L
,
Ng
J
,
Shim
TN
,
Doiron
PR
,
Watchorn
R
, et al.
The management of penile intraepithelial neoplasia (PeIN): clinical and histological features and treatment of 345 patients and a review of the literature
.
J Dermatol Treat
.
2020
:
1
16
.

20

Kravvas
G
,
Shim
TN
,
Doiron
PR
,
Freeman
A
,
Jameson
C
,
Minhas
S
, et al.
The diagnosis and management of male genital lichen sclerosus: a retrospective review of 301 patients
.
J Eur Acad Dermatol Venereol
.
2018
;
32
(
1
):
91
95
.

21

Edmonds
EV
,
Hunt
S
,
Hawkins
D
,
Dinneen
M
,
Francis
N
,
Bunker
CB
.
Clinical parameters in male genital lichen sclerosus: a case series of 329 patients
.
J Eur Acad Dermatol Venereol
.
2012
;
26
(
6
):
730
737
.

22

Liatsikos
EN
,
Perimenis
P
,
Dandinis
K
,
Kaladelfou
E
,
Barbalias
G
.
Lichen sclerosus et atrophicus. Findings after complete circumcision
.
Scand J Urol Nephrol
.
1997
;
31
(
5
):
453
456
.

23

Bottles
K
,
Lacey
CG
,
Goldberg
J
,
Lanner-Cusin
K
,
Hom
J
,
Miller
TR
.
Merkel cell carcinoma of the vulva
.
Obstet Gynecol
.
1984
;
63
(
3 Suppl
):
61s
65s
.

24

Santos-Briz
A
,
Antúnez
P
,
López-Ríos
F
,
Rodríguez-Peralto
JL
,
Garzón
A
.
Human papillomavirus-negative spindle cell carcinoma of the vulva associated with lichen sclerosus: case report and literature review
.
Am J Dermatopathol
.
2002
;
24
(
2
):
135
138
.

25

Thomas
RH
,
McGibbon
DH
,
Munro
DD
.
Basal cell carcinoma of the vulva in association with vulval lichen sclerosus et atrophicus
.
J R Soc Med
.
1985
;
78
(
Suppl 11
):
16
18
.

26

Hieta
NK
,
Kurki
SH
,
Rintala
MA
,
Söderlund
JM
,
Hietanen
SH
,
Katri
OJ
.
Vulvar malignant pleomorphic adenoma in a patient with lichen sclerosus
.
JAAD Case Rep
.
2019
;
5
(
11
):
994
996
.

27

Yap
J
,
O'Neill
D
,
Nagenthiran
S
,
Dawson
CW
,
Luesley
DM
.
Current insights into the aetiology, pathobiology, and management of local disease recurrence in squamous cell carcinoma of the vulva
.
BJOG
.
2017
;
124
(
6
):
946
954
.

28

Ottaviano
M
,
Giunta
EF
,
Marandino
L
,
Tortora
M
,
Attademo
L
,
Bosso
D
, et al.
Anorectal and genital mucosal melanoma: diagnostic challenges, current knowledge and therapeutic opportunities of rare melanomas
.
Biomedicines
.
2022
;
10
(
1
):150.

29

Ragnarsson-Olding
B
,
Johansson
H
,
Rutqvist
LE
,
Ringborg
U
.
Malignant melanoma of the vulva and vagina. Trends in incidence, age distribution, and long-term survival among 245 consecutive cases in Sweden 1960–1984
.
Cancer
.
1993
;
71
(
5
):
1893
1897
. 10.1002/1097-0142(19930301)71:5<1893::aid-cncr2820710528>3.0.co;2-7

30

Weinstock
MA
.
Malignant melanoma of the vulva and vagina in the United States: patterns of incidence and population-based estimates of survival
.
Am J Obstet Gynecol
.
1994
;
171
(
5
):
1225
1230
.

31

Cakir
OO
,
Pozzi
E
,
Castiglione
F
,
Freeman
A
,
Haider
A
,
Rees
R
, et al.
Clinical features, molecular characteristics and surgical management of primary penile mucosal melanoma based on the European Association of Urology Penile Cancer Guidelines
.
Melanoma Res
.
2022
;
32
(
1
):
27
34
.

32

Ragnarsson-Olding
BK
.
Primary malignant melanoma of the vulva – an aggressive tumor for modeling the genesis of non-UV light-associated melanomas
.
Acta Oncol
.
2004
;
43
(
5
):
421
435
.

33

Bader
JL
,
Li
FP
,
Olmstead
PM
,
Strickman
NA
,
Green
DM
.
Childhood malignant melanoma. Incidence and etiology
.
Am J Pediatr Hematol Oncol
.
1985
;
7
(
4
):
341
345
.

34

Whiteman
D
,
Valery
P
,
McWhirter
W
,
Green
A
.
Incidence of cutaneous childhood melanoma in Queensland, Australia
.
Int J Cancer
.
1995
;
63
(
6
):
765
768
.

35

Grob
J
,
Gaudy-Marqueste
C
. Melanoma clinicopathology. In:
Griffiths
C
,
Barker
J
,
Bleiker
T
,
Chalmers
R
,
Creamer
T
, editors.
Rook's textbook of dermatology
. 9th ed.
Chichester
:
Wiley-Blackwell
;
2016
. 4696 p.

36

Papeš
D
,
Altarac
S
,
Arslani
N
,
Rajković
Z
,
Antabak
A
,
Ćaćić
M
.
Melanoma of the glans penis and urethra
.
Urology
.
2014
;
83
(
1
):
6
11
.

37

McLaughlin
CC
,
Wu
XC
,
Jemal
A
,
Martin
HJ
,
Roche
LM
,
Chen
VW
.
Incidence of noncutaneous melanomas in the U.S.
Cancer
.
2005
;
103
(
5
):
1000
1007
.

38

Zaffar
M
,
Scott
HJ
.
Vaginal melanoma: a current review
.
J Obstet Gynaecol
.
1998
;
18
(
6
):
516
519
.

39

Ragnarsson-Olding
BK
,
Kanter-Lewensohn
LR
,
Lagerlöf
B
,
Nilsson
BR
,
Ringborg
UK
.
Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: clinical observations and histopathologic features
.
Cancer
.
1999
;
86
(
7
):
1273
1284
. 10.1002/(sici)1097-0142(19991001)86:7<1273::aid-cncr24>3.0.co;2-z

40

Alexander
A
,
Harris
RM
,
Grossman
D
,
Bruggers
CS
,
Leachman
SA
.
Vulvar melanoma: diffuse melanosis and metastasis to the placenta
.
J Am Acad Dermatol
.
2004
;
50
(
2
):
293
298
.

41

Chang
AE
,
Karnell
LH
,
Menck
HR
.
The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society
.
Cancer
.
1998
;
83
(
8
):
1664
1678
. 10.1002/(sici)1097-0142(19981015)83:8<1664::aid-cncr23>3.0.co;2-g

42

Lotem
M
,
Anteby
S
,
Peretz
T
,
Ingber
A
,
Avinoach
I
,
Prus
D
.
Mucosal melanoma of the female genital tract is a multifocal disorder
.
Gynecol Oncol
.
2003
;
88
(
1
):
45
50
.

43

Carlson
JA
,
Lamb
P
,
Malfetano
J
,
Ambros
RA
,
Mihm
MC
, Jr
.
Clinicopathologic comparison of vulvar and extragenital lichen sclerosus: histologic variants, evolving lesions, and etiology of 141 cases
.
Mod Pathol
.
1998
;
11
(
9
):
844
854
.

44

Drut
RM
,
Gómez
MA
,
Drut
R
,
Lojo
MM
.
Human papillomavirus is present in some cases of childhood penile lichen sclerosus: an in situ hybridization and SP-PCR study
.
Pediatr Dermatol
.
1998
;
15
(
2
):
85
90
.

45

Kiene
P
,
Milde-Langosch
K
,
Löning
T
.
Human papillomavirus infection in vulvar lesions of lichen sclerosus et atrophicus
.
Arch Dermatol Res
.
1991
;
283
(
7
):
445
448
.

46

Haefner
HK
,
Tate
JE
,
McLachlin
CM
,
Crum
CP
.
Vulvar intraepithelial neoplasia: age, morphological phenotype, papillomavirus DNA, and coexisting invasive carcinoma
.
Hum Pathol
.
1995
;
26
(
2
):
147
154
.

47

Ansink
AC
,
Krul
MR
,
De Weger
RA
,
Kleyne
JA
,
Pijpers
H
,
Van Tinteren
H
, et al.
Human papillomavirus, lichen sclerosus, and squamous cell carcinoma of the vulva: detection and prognostic significance
.
Gynecol Oncol
.
1994
;
52
(
2
):
180
184
.

48

Nasca
MR
,
Innocenzi
D
,
Micali
G
.
Penile cancer among patients with genital lichen sclerosus
.
J Am Acad Dermatol
.
1999
;
41
(
6
):
911
914
.

49

Kagie
MJ
,
Kenter
GG
,
Zomerdijk-Nooijen
Y
,
Hermans
J
,
Schuuring
E
,
Timmers
PJ
, et al.
Human papillomavirus infection in squamous cell carcinoma of the vulva, in various synchronous epithelial changes and in normal vulvar skin
.
Gynecol Oncol
.
1997
;
67
(
2
):
178
183
.

50

Carlson
JA
,
Amin
S
,
Malfetano
J
,
Tien
AT
,
Selkin
B
,
Hou
J
, et al.
Concordant p53 and mdm-2 protein expression in vulvar squamous cell carcinoma and adjacent lichen sclerosus
.
Appl Immunohistochem Mol Morphol
.
2001
;
9
(
2
):
150
163
.

51

Carlson
JA
,
Healy
K
,
Tran
TA
,
Malfetano
J
,
Wilson
VL
,
Rohwedder
A
, et al.
Chromosome 17 aneusomy detected by fluorescence in situ hybridization in vulvar squamous cell carcinomas and synchronous vulvar skin
.
Am J Pathol
.
2000
;
157
(
3
):
973
983
.

52

Carlson
JA
,
Grabowski
R
,
Chichester
P
,
Paunovich
E
,
Malfetano
J
.
Comparative immunophenotypic study of lichen sclerosus: epidermotropic CD57+ lymphocytes are numerous – implications for pathogenesis
.
Am J Dermatopathol
.
2000
;
22
(
1
):
7
16
.

53

Carlson
JA
,
Grabowski
R
,
Mu
XC
,
Del Rosario
A
,
Malfetano
J
,
Slominski
A
.
Possible mechanisms of hypopigmentation in lichen sclerosus
.
Am J Dermatopathol
.
2002
;
24
(
2
):
97
107
.

54

Slominski
A
,
Paus
R
,
Bomirski
A
.
Hypothesis: possible role for the melatonin receptor in vitiligo: discussion paper
.
J R Soc Med
.
1989
;
82
(
9
):
539
541
.

55

Riley
PA
.
Melanin
.
Int J Biochem Cell Biol
.
1997
;
29
(
11
):
1235
1239
.

56

Hahn
H
.
Genetically determined susceptibility markers in skin cancer and their application to chemoprevention
.
IARC Sci Publ
.
2001
;
154
:
93
100
.

57

La Placa
M
,
Ambretti
S
,
Bonvicini
F
,
Venturoli
S
,
Bianchi
T
,
Varotti
C
, et al.
Presence of high-risk mucosal human papillomavirus genotypes in primary melanoma and in acquired dysplastic melanocytic naevi
.
Br J Dermatol
.
2005
;
152
(
5
):
909
914
.

58

Ueda
Y
,
Enomoto
T
,
Miyatake
T
,
Shroyer
KR
,
Yoshizaki
T
,
Kanao
H
, et al.
Analysis of clonality and HPV infection in benign, hyperplastic, premalignant, and malignant lesions of the vulvar mucosa
.
Am J Clin Pathol
.
2004
;
122
(
2
):
266
274
.

59

Zaki
I
,
Dalziel
KL
,
Solomonsz
FA
,
Stevens
A
.
The under-reporting of skin disease in association with squamous cell carcinoma of the vulva
.
Clin Exp Dermatol
.
1996
;
21
(
5
):
334
337
.

60

Friedman
RJ
,
Kopf
AW
,
Jones
WB
.
Malignant melanoma in association with lichen sclerosus on the vulva of a 14-year-old
.
Am J Dermatopathol
.
1984
;
6
(
Suppl
):
253
256
.

61

Carlson
JA
,
Mihm
MC
.
Vulvar nevi, lichen sclerosus et atrophicus, and vitiligo
.
Arch Dermatol
.
1997
;
133
(
10
):
1314
1316
.

62

Kornberg
R
,
Ackerman
AB
.
Pseudomelanoma: recurrent melanocytic nevus following partial surgical removal
.
Arch Dermatol
.
1975
;
111
(
12
):
1588
1590
.

63

Sexton
M
,
Sexton
CW
.
Recurrent pigmented melanocytic nevus. A benign lesion, not to be mistaken for malignant melanoma
.
Arch Pathol Lab Med
.
1991
;
115
(
2
):
122
126
.

64

Park
HK
,
Leonard
DD
,
Arrington
JH
, 3rd
,
Lund
HZ
.
Recurrent melanocytic nevi: clinical and histologic review of 175 cases
.
J Am Acad Dermatol
.
1987
;
17
(
2 Pt 1
):
285
292
.

65

El Shabrawi-Caelen
L
,
Soyer
HP
,
Schaeppi
H
,
Cerroni
L
,
Schirren
CG
,
Rudolph
C
, et al.
Genital lentigines and melanocytic nevi with superimposed lichen sclerosus: a diagnostic challenge
.
J Am Acad Dermatol
.
2004
;
50
(
5
):
690
694
.

66

Tekin
HG
,
Skyum
H
,
Spaun
E
,
Juel
J
.
Lichen sclerosus-associated nevus on glans penis mimicking melanoma
.
JAAD Case Rep
.
2020
;
6
(
4
):
323
325
.

67

Sollena
P
,
Caldarola
G
,
Di Stefani
A
,
Massi
G
,
Peris
K
.
Lichen sclerosus of the glans simulating melanoma
.
J Am Acad Dermatol
.
2017
;
76
(
2s1
):
S49
S51
.

This is an open access article under the terms of the https://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.